ATE385574T1 - Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen - Google Patents

Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen

Info

Publication number
ATE385574T1
ATE385574T1 AT03706157T AT03706157T ATE385574T1 AT E385574 T1 ATE385574 T1 AT E385574T1 AT 03706157 T AT03706157 T AT 03706157T AT 03706157 T AT03706157 T AT 03706157T AT E385574 T1 ATE385574 T1 AT E385574T1
Authority
AT
Austria
Prior art keywords
cell sample
melatonin
signaling pathway
idiopathic scoliosis
related diseases
Prior art date
Application number
AT03706157T
Other languages
English (en)
Inventor
Alain Moreau
Original Assignee
Chu Sainte Justine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu Sainte Justine filed Critical Chu Sainte Justine
Application granted granted Critical
Publication of ATE385574T1 publication Critical patent/ATE385574T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Testing Of Engines (AREA)
  • Saccharide Compounds (AREA)
AT03706157T 2002-02-28 2003-02-28 Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen ATE385574T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002373854A CA2373854A1 (en) 2002-02-28 2002-02-28 Methods of diagnosing and counteracting adolescent idiopathic scoliosis

Publications (1)

Publication Number Publication Date
ATE385574T1 true ATE385574T1 (de) 2008-02-15

Family

ID=27762090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03706157T ATE385574T1 (de) 2002-02-28 2003-02-28 Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen

Country Status (11)

Country Link
US (7) US20050130250A1 (de)
EP (1) EP1478928B1 (de)
AT (1) ATE385574T1 (de)
AU (1) AU2003208204A1 (de)
CA (1) CA2373854A1 (de)
CY (1) CY1107358T1 (de)
DE (1) DE60318987T2 (de)
DK (1) DK1478928T3 (de)
ES (1) ES2298498T3 (de)
PT (1) PT1478928E (de)
WO (1) WO2003073102A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373854A1 (en) 2002-02-28 2003-08-28 Alain Moreau Methods of diagnosing and counteracting adolescent idiopathic scoliosis
US20090035772A1 (en) * 2007-07-03 2009-02-05 Axial Biotech, Inc. Genetic Markers Associated With Scoliosis And Uses Thereof
US20090035769A1 (en) * 2007-12-31 2009-02-05 Nelson Lesa M Genetic Markers Associated with Scoliosis and Uses Thereof
US20090104620A1 (en) * 2007-07-03 2009-04-23 Axial Biotech, Inc. Simplified Method of Determining Predisposition to Scoliosis
US7655403B2 (en) * 2006-12-02 2010-02-02 Texas Scottish Rite Hospital For Children CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis
AU2008229601B2 (en) * 2007-03-19 2013-05-02 Chu Sainte-Justine Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
US20100075333A1 (en) * 2007-03-30 2010-03-25 Alain Moreau Method of determining the risk of scoliosis
TWI443337B (zh) * 2008-10-10 2014-07-01 Ct Hospitalier Universitaire Sainte Justine 用於脊柱側彎之分類及診斷的方法
ES2616808T3 (es) * 2010-10-04 2017-06-14 Chu Sainte-Justine Métodos de base biomecánica de diagnóstico de escoliosis
EP3010541B1 (de) 2013-06-17 2019-04-10 Chu Sainte-Justine Verfahren zur diagnostik einer skoliotischen person
KR20160020552A (ko) 2013-06-17 2016-02-23 슈 생-쥐스땡 척추측만증 및 척추측만증 진행에 대한 마커로서 Gi 단백질 인산화, 척추측만 개체에서 GiPCR 신호전달을 증가시키는 방법
EP3011332B1 (de) 2013-06-17 2019-09-18 CHU Sainte-Justine Neue marker des schwierigen verlaufs von idiopathischer skoliose und verwendungen davon zur unterteilung von skoliosepatienten und zur vorhersage des risikos der entwicklung von skoliose
WO2015032004A1 (en) 2013-09-09 2015-03-12 Chu Sainte-Justine Method of treating and prognosing scoliotic patient subgroups
MX382711B (es) 2014-09-25 2025-03-13 Biora Therapeutics Inc Dispositivo de pildora electromecanica con capacidades de localizacion.
CA2989480C (en) * 2015-06-16 2024-03-05 Centro De Investigacion Biomedica En Red (Ciber) Kit and method for the diagnosis/prognosis of idiopathic scoliosis
JP7153633B2 (ja) * 2016-08-18 2022-10-14 ビオラ・セラピューティクス・インコーポレイテッド サンプリングシステム、ならびに関連する材料および方法
CN115591091A (zh) 2016-09-09 2023-01-13 比奥拉治疗股份有限公司(Us) 用于递送可配发物质的机电可摄入装置
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3600009B1 (de) 2017-03-31 2020-12-30 Progenity, Inc. Schluckbare vorrichtung mit lokalisierungsfähigkeit
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
CN111575361A (zh) * 2020-04-20 2020-08-25 孙欣 一种褪黑素通路调控因子治疗ais患者的测试方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856124A (en) * 1994-06-17 1999-01-05 The General Hospital Corporation DNA encoding high-affinity melatonin receptors
DE69735852D1 (de) * 1996-07-18 2006-06-14 Gen Hospital Corp Regulatorische regionen des gens für den melatonin 1a rezeptor und deren verwendungen
JPH119282A (ja) * 1997-06-19 1999-01-19 Nippon Chem Res Kk メラトニン受容体発現細胞とその用途
AU6385200A (en) * 1999-07-30 2001-02-19 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders
CA2373854A1 (en) 2002-02-28 2003-08-28 Alain Moreau Methods of diagnosing and counteracting adolescent idiopathic scoliosis

Also Published As

Publication number Publication date
DK1478928T3 (da) 2008-05-19
AU2003208204A1 (en) 2003-09-09
EP1478928B1 (de) 2008-02-06
US7989175B2 (en) 2011-08-02
US8652791B2 (en) 2014-02-18
US20160258947A1 (en) 2016-09-08
US20050130250A1 (en) 2005-06-16
DE60318987D1 (de) 2008-03-20
US20090111110A1 (en) 2009-04-30
CA2373854A1 (en) 2003-08-28
US20120009600A1 (en) 2012-01-12
US20110256582A1 (en) 2011-10-20
DE60318987T2 (de) 2009-01-29
WO2003073102A1 (en) 2003-09-04
ES2298498T3 (es) 2008-05-16
HK1071601A1 (en) 2005-07-22
US20130115615A1 (en) 2013-05-09
US20140113313A1 (en) 2014-04-24
EP1478928A1 (de) 2004-11-24
PT1478928E (pt) 2008-04-09
CY1107358T1 (el) 2012-12-19

Similar Documents

Publication Publication Date Title
ATE385574T1 (de) Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
EP1563300A4 (de) Diagnoseverfahren für sprue/zeliakie
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
EP2520935A3 (de) Organspezifische Proteine und Verfahren zu deren Verwendung
DE602004026014D1 (de) Verfahren zum Nachweis von medizinisch relevanten Zuständen in gelösten LBC-Proben
MXPA03000226A (es) Diagnosticos tempranos de enfermedades conformacionales.
DE60320867D1 (de) Verfahren und vorrichtung zur charakterisierung von analyten
EA200600452A1 (ru) Автоматизированные способы и системы для обнаружения и анализа сосудистых бляшек
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
ATE418072T1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
EP1543331A4 (de) Verfahren zur diagnose von morbus alzheimer
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
ATE520987T1 (de) Verfahren zum nachweis und/oder screening zur überwachung eines kolorektalkrebs in einem individuum
EP2508886A3 (de) Mittel und Verfahren zur Klassifizierung von Proben von Multiple-Sklerose-Patienten.
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATA19972000A (de) Pibf für die diagnose von tumoren
SE0200974D0 (sv) Screening method for gastritis
DE60326269D1 (de) Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1478928

Country of ref document: EP

REN Ceased due to non-payment of the annual fee